No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma

Neuropathol Appl Neurobiol. 2004 Jun;30(3):304-7. doi: 10.1046/j.0305-1846.2004.00538.x.

Abstract

Choroid plexus carcinomas (CPC) have been shown to carry mutations in the hSNF5/INI1 gene on chromosomal arm 22q11.2. A recent study on choroid plexus papillomas (CPP) and CPC revealed frequent losses of chromosomal portions on the long arm of chromosome 22 (-22q). The region harbouring hSNF5/INI1 was affected in 47% of the CPP and 73% of the CPC, respectively. -22q occurred more frequently in adult than in infantile CPP suggesting different pathogenetic pathways for these tumours. These findings may indicate a potential tumour suppressor gene function of hSNF5/INI1 in a subset of choroid plexus tumours. In order to examine its potential role in the pathogenesis of choroid plexus tumours, we analysed exons 1-9 of hSNF5/INI1 by SSCP analysis in a series of 21 formalin-fixed and paraffin-embedded CPP. No alterations in migratory patterns were detected. These data indicate that somatic point mutations of hSNF5/INI1 do not play a role in the pathogenesis of CPP and that CPP and CPC may arise by two different molecular pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Choroid Plexus Neoplasms / genetics*
  • Chromosomal Proteins, Non-Histone
  • Chromosomes, Human, Pair 22 / genetics
  • DNA Mutational Analysis
  • DNA-Binding Proteins / genetics*
  • Exons / genetics
  • Humans
  • Papilloma, Choroid Plexus / genetics*
  • Point Mutation / genetics*
  • Polymorphism, Single-Stranded Conformational
  • SMARCB1 Protein
  • Tissue Fixation
  • Transcription Factors

Substances

  • Chromosomal Proteins, Non-Histone
  • DNA-Binding Proteins
  • SMARCB1 Protein
  • SMARCB1 protein, human
  • Transcription Factors